Papillomavirus infection requires gamma secretase. (1/19)

Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein. (2/19)

Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway. (3/19)

HPV episome levels are potently decreased by pyrrole-imidazole polyamides. (4/19)

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. (5/19)

Multiplex detection and SNP genotyping in a single fluorescence channel. (6/19)

Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide. (7/19)

Differentiation-dependent changes in levels of C/EBPbeta repressors and activators regulate human papillomavirus type 31 late gene expression. (8/19)

• 1
• 2
• 3